SFX by Ex Libris Inc.

Title:	Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition
Source:	Nature Biotechnology [1087-0156] Kleinstiver, Benjamin yr:2015

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Wang, J. "Structural and Mechanistic Basis of PAM-Dependent Spacer Acquisition in CRISPR-Cas Systems." Cell 163.4 (2015): 840-53.
description	2.	Kleinstiver, Benjamin P. P. "Engineered CRISPR-Cas9 nucleases with altered PAM specificities." Nature 523.7561 (2015): 481-485.
description	3.	Sternberg, Samuel H. "Conformational control of DNA target cleavage by CRISPR-Cas9." Nature 527.7576 (2015): 110-3.
description	4.	Ran, Winston A. "In vivo genome editing using Staphylococcus aureus Cas9." Nature 520.7546 (2015): 186-91.
description	5.	Bi, L. "Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A." Nature genetics 10.1 (1995): 119-121.
description	6.	Shipman, Seth L. "Molecular recordings by directed CRISPR spacer acquisition." Science 353.6298 (2016): 463-463.
description	7.	Hsu, P. "Development and Applications of CRISPR-Cas9 for Genome Engineering." Cell 157.6 (2014): 1262-1278.
description	8.	Shalem, O. "Genome-scale CRISPR-Cas9 knockout screening in human cells." Science 343.6166 (2014): 84-87.
description	9.	Barrangou, R. "CRISPR provides acquired resistance against viruses in prokaryotes." Science 315.5819 (2007): 1709-12.
description	10.	Konermann, S. "Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex." Nature 517.7536 (2014): 583-8.
description	11.	Knight, J.-B. C. "Dynamics of CRISPR-Cas9 genome interrogation in living cells." Science 350.6262 (2015): 823-826.
description	12.	Slaymaker, Ian M. "Rationally engineered Cas9 nucleases with improved specificity." Science 351.6268 (2015): 84-8.
description	13.	Quetier, F. "The CRISPR-Cas9 technology: Closer to the ultimate toolkit for targeted genome editing." Plant science 242.Sp. Iss. SI (2016): 65-76.
description	14.	Pellagatti, A. "Application of CRISPR/Cas9 genome editing to the study and treatment of disease." Archives of toxicology 89.7 (2015): 1023-1034.
description	15.	Chavez, A. "Highly efficient Cas9-mediated transcriptional programming." Nature Methods 12.4 (2015): 326-8.
description	16.	Nuñez, James K. "Integrase-mediated spacer acquisition during CRISPR-Cas adaptive immunity." Nature 519.7542 (2015): 193-198.
description	17.	Yosef, I. "DNA motifs determining the efficiency of adaptation into the Escherichia coli CRISPR array." Proceedings of the National Academy of Sciences of the United States of America 110.35 (2013): 14396-14401.
description	18.	Gasiunas, T. "In vitro reconstitution of Cascade-mediated CRISPR immunity in Streptococcus thermophilus." EMBO journal 32.3 (2013): 385-394.
description	19.	Cong, David e. "Multiplex Genome Engineering Using CRISPR/Cas Systems." Science 339.6121 (2013): 819-823.
description	20.	Koo, T. "Measuring and Reducing Off-Target Activities of Programmable Nucleases Including CRISPR-Cas9." Molecules and Cells 38.6 (2015): 475-81.